Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Blocklisting Six Monthly Return

2 Jun 2015 17:10

RNS Number : 0061P
Premier Veterinary Group PLC
02 June 2015
 



 

Premier Veterinary Group plc

 

2 June 2015

 

BLOCKLISTING SIX MONTHLY RETURN

 

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

2,271,252

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

2,271,252

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

939,433

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

683,200

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

683,200

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no awards outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Approved Share Option Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

1,000,000

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

Name of contact:

Sue Steven, Company Secretary

Telephone number of contact:

+44(0)117 970 4127

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLREAKKAEENSEFF
Date   Source Headline
10th Mar 20101:21 pmRNSEPT Disclosure
10th Mar 201011:52 amRNSEPT Disclosure
10th Mar 20107:00 amRNSFinal Results
9th Mar 20107:00 amRNSResearch Update
8th Mar 20105:34 pmRNSHolding(s) in Company
23rd Feb 20107:00 amRNSResearch Update
19th Feb 20107:00 amRNSRe Agreement
16th Feb 20104:40 pmRNSSecond Price Monitoring Extn
16th Feb 20104:35 pmRNSPrice Monitoring Extension
11th Feb 201011:37 amRNSDirector/PDMR Shareholding
5th Feb 20104:35 pmRNSPrice Monitoring Extension
29th Jan 20103:23 pmRNSTotal Voting Rights
28th Jan 201011:05 amRNSNotice of Results
28th Jan 20107:02 amRNSResearch Update
28th Jan 20107:00 amRNSResearch Update
20th Jan 20103:51 pmRNSEmployee Benefit Trust
5th Jan 20107:00 amRNSArk files for re-examination of Cerepro
22nd Dec 20094:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20094:35 pmRNSPrice Monitoring Extension
18th Dec 200911:56 amRNSEMEA recommendation on Cerepro
15th Dec 20092:29 pmRNSHolding(s) in Company
3rd Dec 20092:41 pmRNSBlocklisting Interim Review
3rd Dec 20092:35 pmRNSHolding(s) in Company
24th Nov 20094:04 pmRNSHolding(s) in Company
11th Nov 20097:00 amRNSInterim Management Statement
14th Oct 20097:00 amRNSResearch Update
2nd Oct 200911:04 amRNSHolding(s) in Company
30th Sep 200910:51 amRNSHolding(s) in Company
29th Sep 20094:32 pmRNSHolding(s) in Company
4th Sep 20097:00 amRNSResearch Update
1st Sep 200912:08 pmRNSDirector/PDMR Shareholding
26th Aug 20097:00 amRNSResearch Update
26th Aug 20097:00 amRNSHalf Yearly Report
13th Jul 20097:00 amRNSArk launches Kerraglove woundcare device
1st Jul 20097:00 amRNSRe Agreement
26th Jun 20092:15 pmRNSHolding(s) in Company
24th Jun 20097:00 amRNSManufacturing Update
17th Jun 20097:00 amRNSRe Agreement
3rd Jun 200911:47 amRNSBlocklisting Interim Review
21st May 20097:00 amRNSTrinam Phase III Study Enrols First Patient
18th May 20097:00 amRNSInterim Management Statement
15th May 20097:00 amRNSCerepro Named Patient Supply approved in Finland
13th May 20094:41 pmRNSSecond Price Monitoring Extn
13th May 20094:35 pmRNSPrice Monitoring Extension
12th May 20097:00 amRNSDirector/PDMR Shareholding
6th May 20094:40 pmRNSSecond Price Monitoring Extn
6th May 20094:35 pmRNSPrice Monitoring Extension
5th May 20097:00 amRNSTrinam(R) Awarded Fast Track Status by FDA
30th Apr 20094:01 pmRNSTotal Voting Rights
30th Apr 200912:00 pmRNSPrestigious European Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.